Guided Therapeutics, Inc.
GTHP
$0.1088
$0.00888.80%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.42M | -2.15M | -2.17M | -3.02M | -3.49M |
| Total Depreciation and Amortization | 95.00K | 93.00K | 90.00K | 88.00K | 85.00K |
| Total Amortization of Deferred Charges | 93.00K | 105.00K | 115.00K | 130.00K | 130.00K |
| Total Other Non-Cash Items | 107.00K | -68.00K | 35.00K | 1.12M | 1.63M |
| Change in Net Operating Assets | 1.00M | 898.00K | 811.00K | 341.00K | -105.00K |
| Cash from Operations | -1.12M | -1.12M | -1.12M | -1.35M | -1.75M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 587.00K | 387.00K | 200.00K | -- | -- |
| Total Debt Repaid | -477.00K | -313.00K | -384.00K | -286.00K | -412.00K |
| Issuance of Common Stock | 835.00K | 541.00K | 241.00K | 241.00K | 436.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -29.00K | -29.00K | -17.00K | -- | -- |
| Cash from Financing | 916.00K | 586.00K | 40.00K | -45.00K | 24.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -203.00K | -537.00K | -1.08M | -1.39M | -1.72M |